Remove 2020 Remove COVID-19 Vaccine Remove Governance
article thumbnail

COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues

Bill of Health

In October 2020, Moderna pledged not to enforce its patents amid the ongoing pandemic. More broadly, BioNTech and Pfizer highlight Moderna’s surreptitious conduct of obtaining its mRNA patents without disclosing the government’s role in its funding and development. Moderna has since made over $30 billion in COVID-19 vaccine sales.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. government funding, announced that it felt “a special obligation … to use our resources to bring this pandemic to an end as quickly as possible.” From 2020 to 2022, the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Judging in the Pandemic – A Malawian Perspective

Bill of Health

Kathumba case: separation of powers, social security, and lockdowns The Khatumba case involved an order made by the Minister of Health for a temporary, national 3-week lockdown from April 18, 2020 to May 2020 due an increase in COVID-19 cases. Ultimately, the Court upheld the applicants’ challenges for a range of reasons.

COVID-19 307
article thumbnail

The Proposed TRIPS Compromise Risks Setting Several Bad Precedents

Bill of Health

The original proposal tabled by India and South Africa in 2020 as IP/C/W/669 would have waived 40 articles of the WTO Trade Related Agreement on Intellectual Property Rights, known as the TRIPS. The notion that certain TRIPS flexibilities are exceptional to the COVID-19 crisis. Requirement to list the specific patents.

COVID-19 363
article thumbnail

The Impossibility of Legal Accountability for COVID-19 Torts

Bill of Health

Since the first days of the COVID-19 pandemic, employers, businesses, and other entities have anticipated litigation around tort claims associated with the novel coronavirus. Early in 2020, scholars here began to grapple with questions of tort liability relating to the pandemic response. Legal limitations and strategies.

COVID-19 348
article thumbnail

How to Fairly Allocate Scarce COVID-19 Therapies

Bill of Health

The Delta variant led the federal government to resume control over mAb supply and promulgate allocation guidelines. Older and medically vulnerable people who continue to face high risk of COVID-19 illness after vaccination should not be asked to wait in line behind adults who refused vaccines.

COVID-19 211
article thumbnail

More than 591 million EU Digital COVID Certificates issued since June 2021

Healthcare It News

More than 591 million EU Digital COVID Certificates (EUDCC) have now been generated, according to a European Commission report published today. The certificate, which covers COVID-19 vaccination, test and recovery, aims to facilitate safe travel for citizens in Europe. THE LARGER CONTEXT.

COVID-19 230